Patents by Inventor Sigbrit Forsman

Sigbrit Forsman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immediate release tablet
    Publication number: 20050208128
    Abstract: A new oral IR formulation in solid form for a low molecular weight thrombin inhibitor having pH dependant dissolution, characterized in that the formulation comprises a filler or a combination of fillers having disintegrant properties in an amount higher than 35% w/w of the formulation.
    Type: Application
    Filed: March 31, 2005
    Publication date: September 22, 2005
    Inventors: Sigbrit Forsman, Christer Karlsson, Magnus Karlsson
  • Method for prophylaxis and/or treatment of thromboembolism
    Patent number: 6875446
    Abstract: A new oral IR formulation in solid form for a low molecular weight thrombin inhibitor having pH dependant dissolution, characterized in that the formulation comprises a filler or a combination of fillers having disintegrant properties in an amount higher than 35% w/w of the formulation.
    Type: Grant
    Filed: January 21, 2003
    Date of Patent: April 5, 2005
    Assignee: AstraZeneca AB
    Inventors: Sigbrit Forsman, Christer Karlsson, Magnus Karlsson
  • Method for prophylaxis and/or treatment of thromboembolism
    Publication number: 20030118644
    Abstract: A new oral IR formulation in solid form for a low molecular weight thrombin inhibitor having pH dependant dissolution, characterized in that the formulation comprises a filler or a combination of fillers having disintegrant properties in an amount higher than 35% W/W of the formulation.
    Type: Application
    Filed: January 21, 2003
    Publication date: June 26, 2003
    Inventors: Sigbrit Forsman, Christer Karlsson, Magnus Karlsson
  • Immediate release tablet
    Patent number: 6521253
    Abstract: A new oral IR formulation in solid form for a low molecular weight thrombin inhibitor having pH dependant dissolution, characterized in that the formulation comprises a filler or a combination of fillers having disintegrant properties in an amount higher than 35% w/w of the formulation.
    Type: Grant
    Filed: November 30, 1999
    Date of Patent: February 18, 2003
    Assignee: AstraZeneca AB
    Inventors: Sigbrit Forsman, Christer Karlsson, Magnus Karlsson